30-Day Notice

Federal Register / Vol. 82, No. 190 / Tuesday, October 3, 2017 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, [email protected].
Name of Committee: Vascular and
Hematology Integrated Review Group;
Vascular Cell and Molecular Biology Study
Section.
Date: October 26–27, 2017.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 27, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–21133 Filed 10–2–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings

asabaliauskas on DSKBBXCHB2PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Ancillary
Studies.
Date: November 1, 2017.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).

VerDate Sep<11>2014

16:49 Oct 02, 2017

Jkt 244001

Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
[email protected].
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Computational and
Experimental Resources for Virome Analysis
in Inflammatory Bowel Disease (CERVAID).
Date: November 14, 2017.
Time: 12:30 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
[email protected].
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–16–034:
Artificial Pancreas Ancillary Studies (R01).
Date: November 15, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 27, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.

46087

provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group NHLBI Mentored
Patient-Oriented Research Review
Committee.
Date: October 26–27, 2017.
Time: 8:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Cambria Hotels & Suites—Rockville,
1 Helen Heneghan Way, Rockville, MD
20850.
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892, 301–
827–7992, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 27, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–21137 Filed 10–2–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration

[FR Doc. 2017–21130 Filed 10–2–17; 8:45 am]

Extension of Agency Information
Collection Activity Under OMB Review:
Critical Facility Information of the Top
100 Most Critical Pipelines

BILLING CODE 4140–01–P

AGENCY:

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

SUMMARY:

National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
NHLBI Mentored Patient-Oriented
Research Review Committee meeting.
The meeting will be closed to the
public in accordance with the

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

Transportation Security
Administration, DHS.
ACTION: 30-day Notice.
This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0050,
abstracted below to OMB for an
extension of the currently approved
collection under the Paperwork
Reduction Act (PRA). The ICR describes
the nature of the information collection
and its expected burden. TSA published
a Federal Register notice, with a 60-day

E:\FR\FM\03OCN1.SGM

03OCN1

46088

Federal Register / Vol. 82, No. 190 / Tuesday, October 3, 2017 / Notices

asabaliauskas on DSKBBXCHB2PROD with NOTICES

comment period soliciting comments, of
the following collection of information
on July 6, 2017, 82 FR 31341. TSA
developed and implemented a plan to
review the security plans and inspect
critical pipeline systems to comply with
a requirement in the Implementing
Recommendations of the 9/11
Commission Act of 2007 (9/11 Act).
DATES: Send your comments by
November 2, 2017. A comment to OMB
is most effective if OMB receives it
within 30 days of publication.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, OMB. Comments should be
addressed to Desk Officer, Department
of Homeland Security/TSA, and sent via
electronic mail to dhsdeskofficer@
omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh, TSA PRA Officer,
Office of Information Technology (OIT),
TSA–11, Transportation Security
Administration, 601 South 12th Street,
Arlington, VA 20598–6011; telephone
(571) 227–2062; email TSAPRA@
tsa.dhs.gov.
SUPPLEMENTARY INFORMATION:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation will be
made available at http://
www.reginfo.gov upon its submission to
OMB. Therefore, in preparation for
OMB review and approval of the
following information collection, TSA is
soliciting comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Consistent with the requirements of
Executive Order (EO) 13771, Reducing
Regulation and Controlling Regulatory
Costs, and EO 13777, Enforcing the
Regulatory Reform Agenda, TSA is also

VerDate Sep<11>2014

18:17 Oct 02, 2017

Jkt 244001

requesting comments on the extent to
which this request for information could
be modified to reduce the burden on
respondents.
Information Collection Requirement
Title: Critical Facility Information of
the Top 100 Most Critical Pipelines.
Type of Request: Extension of a
currently approved collection.
OMB Control Number: 1652–0050.
Forms(s): Critical Facility Security
Review.
Affected Public: Pipeline companies.
Abstract: The 9/11 Act specifically
tasked TSA to develop and implement
a plan for reviewing the pipeline
security plans and inspecting critical
facilities of the 100 most critical
pipeline systems. See sec. 1557 of the 9/
11 Act (Pub. L. 110–53; 121 Stat. 266,
475, Aug. 3, 2007; codified at 6 U.S.C.
1207(b)). TSA visits critical pipeline
facilities and collects site-specific
information from pipeline operators on
facility security policies, procedures,
and physical security measures. TSA
uses the information to determine
strengths and weaknesses at the nation’s
critical pipeline facilities, areas to target
for risk reduction strategies, pipeline
industry implementation of the TSA
Pipeline Security Guidelines, and
operator implementation of
recommendations made during TSA
critical facility visits.
Number of Respondents: 160.
Estimated Annual Burden Hours: An
estimated 720 hours annually.
Dated: September 28, 2017.
Christina A. Walsh,
TSA Paperwork Reduction Act Officer, Office
of Information Technology.
[FR Doc. 2017–21251 Filed 10–2–17; 8:45 am]
BILLING CODE 9110–05–P

INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1072]

2017 and September 21, 2017. The
complaint, as supplemented, alleges
violations of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain Wi-Fi enabled electronic devices
and components thereof by reason of
infringement of certain claims of U.S.
Patent No. 8,325,838 (‘‘the ’838 patent’’)
and U.S. Patent No. 8,279,809 (‘‘the ’809
patent’’). The complaint further alleges
that an industry in the United States
exists as required by the applicable
Federal Statute.
The complainants request that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES: The complaint except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW., Room
112, Washington, DC 20436, telephone
(202) 205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov. The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Pathenia M. Proctor, The Office of
Unfair Import Investigations, U.S.
International Trade Commission,
telephone (202) 205–2560.
SUPPLEMENTARY INFORMATION:

AGENCY:

Authority: The authority for institution of
this investigation is contained in section 337
of the Tariff Act of 1930, as amended, 19
U.S.C. 1337 and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2017).

Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
August 29, 2017, under section 337 of
the Tariff Act of 1930, as amended, on
behalf of Sharp Corporation of Japan
and Sharp Electronics Corporation of
Montvale, New Jersey. Supplements to
the complaint were filed on August 30,

Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
September 26, 2017, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after

Certain Wi-Fi Enabled Electronic
Devices and Components Thereof;
Institution of Investigation
U.S. International Trade
Commission.
ACTION: Notice.
SUMMARY:

PO 00000

Frm 00055

Fmt 4703

Sfmt 4703

E:\FR\FM\03OCN1.SGM

03OCN1